Pacific Biosciences
PACB
PACB
210 hedge funds and large institutions have $4.42B invested in Pacific Biosciences in 2020 Q4 according to their latest regulatory filings, with 72 funds opening new positions, 68 increasing their positions, 54 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
+36
Holders Change %
+20.69%
% of All Funds
3.73%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.11%
New
72
Increased
68
Reduced
54
Closed
35
Calls
$41M
Puts
$40.2M
Net Calls
+$740K
Net Calls Change
-$4.82M
Top Buyers
Top Sellers
1 |
Viking Global Investors
Stamford,
Connecticut
|
-$76.7M |
2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$58.9M |
3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$57.2M |
4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$50.9M |
5 |
BAMCO Inc
New York
|
-$31.4M |